Record U.S. cyclosporiasis outbreak is over, CDC says
People shop at a Manhattan grocery store on August 13, 2026, in New York City. Spencer Platt |…
Rare disease is taking his sight. Access to a treatment is hard to get
Judy and Courtney Stecker with their sons, Read (left) and Wheeler (right). Judy and Courtney Stecker CNBC Cures…
Jim Cramer says investors are too focused on AI stocks. Here’s where he says to look instead
CNBC’s Jim Cramer said Tuesday that investors need to expand their horizons beyond the artificial intelligence trade. “There’s…
With HSAs, employers are turning to the 401(k) playbook
Momo Productions | Digitalvision | Getty Images Employers are increasingly turning to the 401(k) playbook to boost their…
This medical device stock looks like a gift for patient investors
Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…
Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
BioCryst is profitable. Now it wants to buy more rare disease drugs
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories…
FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment
Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…
HHS plans new FDA leadership roles for technology, drugs
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health…
Why vaccination rates are falling in the U.S.
A Medical Assistant gives a measles, mumps and rubella, vaccination to a young person at the pediatric office…
Photos show traditional and conventional medical care in Tibet
LHASA, Tibet (AP) — In the high-altitude region of Tibet, people continue to turn to a centuries-old medical…
BioMarin to acquire Alesta Therapeutics for $275 million
Piotr Swat | Lightrocket | Getty Images CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose…